Wixela vs Trelegy

Wixela vs Trelegy

What to choose Wixela or Trelegy

Wixela and Trelegy are inhalers both of Control type. Wixela and Trelegy are both brand inhalers. Wixela is manufactured by pharmaceutical company Viatris, while Trelegy is manufactured by GSK. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50. The main substances of Trelegy are Fluticasone and Vilanterol. The available dosage for Trelegy is 100 mcg / 25 mcg.

The current price for Wixela is around $240 while actual price for Trelegy is around $619.92, said Matteo Ortiz, an Associate Professor at the Brandeis University and an Advanced Medical Support Assistant at a clinic that uses Wixela and Trelegy.

GENERIC PROAIR from $35.88 per inhaler Buy Now

Wixela and Trelegy Comparison

Trelegy vs Wixela
Wixela Trelegy
Type: Control Control
Manufacturer: Viatris GSK
Substance: Fluticasone + Salmeterol Fluticasone + Vilanterol
Dosage: 250/50 100 mcg / 25 mcg
Avg Price: $240 $619.92

GENERIC SYMBICORT from $53.54 per inhaler Buy Now